These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33086966)

  • 1. A case of granulomatous myositis in a patient with rheumatoid arthritis receiving anti-TNF-α treatment.
    Kawamura A; Tsuchida Y; Shoda H; Kubo K; Uchio N; Shimizu J; Fujio K
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):1-5. PubMed ID: 33086966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-penicillamine-induced myositis in rheumatoid arthritis.
    Chappel R; Willems J
    Clin Rheumatol; 1996 Jan; 15(1):86-7. PubMed ID: 8929785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case of eosinophilic myositis in continuum from localized nodular myositis].
    Matsuse D; Ikezoe K; Shigeto H; Murai H; Ohyagi Y; Kira J
    Rinsho Shinkeigaku; 2008 Jan; 48(1):36-42. PubMed ID: 18386630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute ocular myositis occurring under etanercept for rheumatoid arthritis.
    Couderc M; Mathieu S; Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2014 Oct; 81(5):445-6. PubMed ID: 24746476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis.
    Yoshida A; Katsumata Y; Hirahara S; Hanaoka M; Ochiai M; Kobayashi M; Harigai M
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):156-161. PubMed ID: 32757711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid myositis. Clinical and histologic features and possible pathogenesis.
    Halla JT; Koopman WJ; Fallahi S; Oh SJ; Gay RE; Schrohenloher RE
    Arthritis Rheum; 1984 Jul; 27(7):737-43. PubMed ID: 6378209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series.
    Toussirot E; Berthelot JM; Pertuiset E; Bouvard B; Gaudin P; Wendling D; le Noach J; Lohse A; Lecuyer E; Cri L
    J Rheumatol; 2009 Nov; 36(11):2421-7. PubMed ID: 19797509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic biomarkers and differential effects of TNF- and GM-CSF-targeting biologics in rheumatoid arthritis.
    Guo X; Wang S; Godwood A; Close D; Ryan PC; Roskos LK; White WI
    Int J Rheum Dis; 2019 Apr; 22(4):646-653. PubMed ID: 30358109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-granulomatous myositis in a patient with ulcerative colitis who showed symptoms resembling gastrocnemius myalgia syndrome].
    Yamamoto M; Inoue M; Tachibana N; Tsuzaki K; Shibata Y; Hamano T
    Rinsho Shinkeigaku; 2017 Feb; 57(2):71-76. PubMed ID: 28132973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatoid myositis leading to acute lower extremity compartment syndrome: a case-based review.
    Jo D; Pompa T; Khalil A; Kong F; Wetz R; Goldstein M
    Clin Rheumatol; 2015 Oct; 34(10):1813-6. PubMed ID: 24810700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three cases of anti-TNF induced myositis and literature review.
    Zengin O; Onder ME; Alkan S; Kimyon G; Hüseynova N; Demir ZH; Kısacık B; Onat AM
    Rev Bras Reumatol Engl Ed; 2017; 57(6):590-595. PubMed ID: 29173693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory myopathy with initial respiratory muscles involvement and rheumatoid arthritis].
    Hunter M; Telias I; Collado V; Sarano J; Alvarez C; Suárez JP
    Medicina (B Aires); 2014; 74(5):393-6. PubMed ID: 25347903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry.
    Favalli EG; Sinigaglia L; Becciolini A; Grosso V; Gorla R; Bazzani C; Atzeni F; Sarzi Puttini PC; Fusaro E; Pellerito R; Caporali R
    Int J Rheum Dis; 2018 Feb; 21(2):422-430. PubMed ID: 29082659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contracturing granulomatous myositis in a patient with rheumatoid arthritis: a case report.
    De Ridder W; Van Herck L; Cypers G; Ravelingien I; Baets J
    Neuromuscul Disord; 2024 Mar; 36():38-41. PubMed ID: 38350265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal necrosis in a patient with rheumatoid arthritis receiving anti-TNF treatment.
    Ruppert M; De Clerck L; van Offel J; Hubens G; Balliu L; Vaneerdeweg W
    Acta Chir Belg; 2006; 106(2):225-7. PubMed ID: 16761484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Changes over a Short Period Are Associated with Functional Assessments in Rheumatoid Arthritis.
    Shimizu T; Cruz A; Tanaka M; Mamoto K; Pedoia V; Burghardt AJ; Heilmeier U; Link TM; Graf J; Imboden JB; Li X
    J Rheumatol; 2019 Jul; 46(7):676-684. PubMed ID: 30770506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis and antisynthetase syndrome. A three cases report.
    Wendling D; Golden C; Monet M; Verhoeven F; Guillot X; Prati C
    Joint Bone Spine; 2016 Dec; 83(6):739-740. PubMed ID: 26968110
    [No Abstract]   [Full Text] [Related]  

  • 18. A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis.
    Weinblatt ME; McInnes IB; Kremer JM; Miranda P; Vencovsky J; Guo X; White WI; Ryan PC; Godwood A; Albulescu M; Close D; Burmester GR
    Arthritis Rheumatol; 2018 Jan; 70(1):49-59. PubMed ID: 28941039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.
    Capsoni F; Sarzi-Puttini P; Atzeni F; Minonzio F; Bonara P; Doria A; Carrabba M
    Arthritis Res Ther; 2005; 7(2):R250-5. PubMed ID: 15743471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients.
    Ciechomska M; Bonek K; Merdas M; Zarecki P; Swierkot J; Gluszko P; Bogunia-Kubik K; Maslinski W
    Arch Immunol Ther Exp (Warsz); 2018 Oct; 66(5):389-397. PubMed ID: 29744553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.